160 related articles for article (PubMed ID: 23054033)
1. Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/Vlaardingen study.
Figarska SM; Boezen HM; Vonk JM
Eur J Epidemiol; 2012 Nov; 27(11):867-76. PubMed ID: 23054033
[TBL] [Abstract][Full Text] [Related]
2. Lifetime Smoking History and Cause-Specific Mortality in a Cohort Study with 43 Years of Follow-Up.
Taghizadeh N; Vonk JM; Boezen HM
PLoS One; 2016; 11(4):e0153310. PubMed ID: 27055053
[TBL] [Abstract][Full Text] [Related]
3. NFE2L2 polymorphisms, mortality, and metabolism in the general population.
Figarska SM; Vonk JM; Boezen HM
Physiol Genomics; 2014 Jun; 46(12):411-7. PubMed ID: 24790085
[TBL] [Abstract][Full Text] [Related]
4. ADAM33 gene polymorphisms and mortality. A prospective cohort study.
Figarska SM; Vonk JM; van Diemen CC; Postma DS; Boezen HM
PLoS One; 2013; 8(7):e67768. PubMed ID: 23861802
[TBL] [Abstract][Full Text] [Related]
5. The obesity paradox in patients with peripheral arterial disease.
Galal W; van Gestel YRBM; Hoeks SE; Sin DD; Winkel TA; Bax JJ; Verhagen H; Awara AMM; Klein J; van Domburg RT; Poldermans D
Chest; 2008 Nov; 134(5):925-930. PubMed ID: 18641109
[TBL] [Abstract][Full Text] [Related]
6. Does low vitamin D amplify the association of COPD with total and cardiovascular disease mortality?
Lee HM; Liu M; Lee K; Luo Y; Wong ND
Clin Cardiol; 2014 Aug; 37(8):473-8. PubMed ID: 24719373
[TBL] [Abstract][Full Text] [Related]
7. Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer.
Volpino P; Cangemi R; Fiori E; Cangemi B; De Cesare A; Corsi N; Di Cello T; Cangemi V
J Cardiovasc Surg (Torino); 2007 Jun; 48(3):375-83. PubMed ID: 17505444
[TBL] [Abstract][Full Text] [Related]
8. Co-morbidities and hyperinflation are independent risk factors of all-cause mortality in very severe COPD.
Budweiser S; Harlacher M; Pfeifer M; Jörres RA
COPD; 2014 Aug; 11(4):388-400. PubMed ID: 24111878
[TBL] [Abstract][Full Text] [Related]
9. COPD and risk of venous thromboembolism and mortality in a general population.
Børvik T; Brækkan SK; Enga K; Schirmer H; Brodin EE; Melbye H; Hansen JB
Eur Respir J; 2016 Feb; 47(2):473-81. PubMed ID: 26585434
[TBL] [Abstract][Full Text] [Related]
10. Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample.
Hospers JJ; Schouten JP; Weiss ST; Rijcken B; Postma DS
Am J Respir Crit Care Med; 1999 Dec; 160(6):1869-74. PubMed ID: 10588599
[TBL] [Abstract][Full Text] [Related]
11. Predictors of mortality in patients with stable COPD.
Esteban C; Quintana JM; Aburto M; Moraza J; Egurrola M; España PP; Pérez-Izquierdo J; Capelastegui A
J Gen Intern Med; 2008 Nov; 23(11):1829-34. PubMed ID: 18795373
[TBL] [Abstract][Full Text] [Related]
12. The importance of cardiovascular disease for mortality in patients with COPD: a prognostic cohort study.
Zhang J; Rutten FH; Cramer MJ; Lammers JW; Zuithoff NP; Hoes AW
Fam Pract; 2011 Oct; 28(5):474-81. PubMed ID: 21602286
[TBL] [Abstract][Full Text] [Related]
13. All-cause and cause-specific mortality from restrictive and obstructive spirometric patterns in Chinese adults with and without dyspnea: Guangzhou Biobank Cohort Study.
Pan J; Adab P; Jiang CQ; Zhang WS; Zhu F; Jin YL; Thomas GN; Lam TH
Respir Med; 2019 May; 151():66-80. PubMed ID: 31047120
[TBL] [Abstract][Full Text] [Related]
14. A novel CT-emphysema index/FEV
Loh LC; Ong CK; Koo HJ; Lee SM; Lee JS; Oh YM; Seo JB; Lee SD
Int J Chron Obstruct Pulmon Dis; 2018; 13():2543-2550. PubMed ID: 30174423
[TBL] [Abstract][Full Text] [Related]
15. Association between all-cause and cause-specific mortality and the GOLD stages 1-4: A 30-year follow-up among Finnish adults.
Mattila T; Vasankari T; Kanervisto M; Laitinen T; Impivaara O; Rissanen H; Knekt P; Jousilahti P; Saarelainen S; Puukka P; Heliövaara M
Respir Med; 2015 Aug; 109(8):1012-8. PubMed ID: 26108990
[TBL] [Abstract][Full Text] [Related]
16. Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary disease.
Oga T; Tsukino M; Hajiro T; Ikeda A; Nishimura K
Int J Chron Obstruct Pulmon Dis; 2011; 6():521-6. PubMed ID: 22069363
[TBL] [Abstract][Full Text] [Related]
17. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
[No Abstract] [Full Text] [Related]
18. Chronic obstructive pulmonary disease prognostic score: A new index.
Horita N; Koblizek V; Plutinsky M; Novotna B; Hejduk K; Kaneko T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Jun; 160(2):211-8. PubMed ID: 27364317
[TBL] [Abstract][Full Text] [Related]
19. Lung function and respiratory symptoms in association with mortality: The HUNT Study.
Leivseth L; Nilsen TI; Mai XM; Johnsen R; Langhammer A
COPD; 2014 Feb; 11(1):59-80. PubMed ID: 23875716
[TBL] [Abstract][Full Text] [Related]
20. Eosinophilia is associated with increased all-cause mortality after a follow-up of 30 years in a general population sample.
Hospers JJ; Schouten JP; Weiss ST; Postma DS; Rijcken B
Epidemiology; 2000 May; 11(3):261-8. PubMed ID: 10784241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
